We are live on ! Find out more
REPL icon

Replimune Group

110 hedge funds and large institutions have $1.34B invested in Replimune Group in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

26% more capital invested

Capital invested by funds: $1.06B → $1.34B (+$275M)

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

2% more funds holding

Funds holding: 108110 (+2)

3% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 38

0.12% less ownership

Funds ownership: 74.91%74.8% (-0.12%)

23% less call options, than puts

Call options by funds: $1.56M | Put options by funds: $2.02M

Holders
110
Holders Change
+2
Holders Change %
+1.85%
% of All Funds
1.91%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
15
Increased
39
Reduced
38
Closed
12
Calls
$1.56M
Puts
$2.02M
Net Calls
-$465K
Net Calls Change
+$2.62M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$195M +$68.1M +1,991,208 +65%
OFM
2
Omega Fund Management
Massachusetts
$192M
RG
3
Redmile Group
California
$161M +$2.51M +73,300 +2%
BlackRock
4
BlackRock
New York
$76.1M -$8.06M -235,700 -11%
State Street
5
State Street
Massachusetts
$64.7M -$6.57M -192,121 -10%
Ensign Peak Advisors
6
Ensign Peak Advisors
Utah
$56.2M +$2.11M +61,803 +4%
Vanguard Group
7
Vanguard Group
Pennsylvania
$54.8M -$3.88M -113,380 -7%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$40.5M -$10.6M -310,166 -23%
Loomis, Sayles & Company
9
Loomis, Sayles & Company
Massachusetts
$38.1M +$7.37M +215,411 +28%
BI
10
BVF Inc
California
$35.3M +$15.6M +457,500 +99%
Victory Capital Management
11
Victory Capital Management
Texas
$34.9M -$5.4M -157,826 -15%
AG
12
Artal Group
Luxembourg
$34.6M +$3.42M +100,000 +13%
EMFAT
13
Emerald Mutual Fund Advisers Trust
Pennsylvania
$28.9M -$7.33M -214,435 -22%
EA
14
Emerald Advisers
Pennsylvania
$28.1M -$7.04M -205,759 -22%
Norges Bank
15
Norges Bank
Norway
$23.1M
CS
16
Candriam SCA
Luxembourg
$18.7M +$11.1M +323,828 +200%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$18M +$1.29M +37,865 +9%
CA
18
Corriente Advisors
Texas
$17.3M -$21.4M -625,121 -58%
Morgan Stanley
19
Morgan Stanley
New York
$15.2M +$2.03M +59,323 +18%
Citadel Advisors
20
Citadel Advisors
Florida
$15M -$11.7M -342,821 -47%
Northern Trust
21
Northern Trust
Illinois
$14.4M +$2.79M +81,548 +28%
Wellington Management Group
22
Wellington Management Group
Massachusetts
$14.1M +$12.5M +366,502 New
JP Morgan Chase
23
JP Morgan Chase
New York
$13.4M +$942K +27,547 +9%
Amundi
24
Amundi
France
$10.5M +$9.36M +273,695 New
Two Sigma Advisers
25
Two Sigma Advisers
New York
$9.61M -$1.93M -56,300 -18%

REPL Hedge Fund Activity: Q2 2021 in Review

110 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2021, worth a combined $1.34B — up 26% from $1.06B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new REPL positions and 12 closed out — a net gain of 3 holders — while 39 added to existing stakes and 38 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $68.1M. The largest seller was Corriente Advisors, cutting an estimated $21.4M.

  • 110 institutional investors held Replimune Group (REPL) as of Q2 2021, up from 108 in Q1 2021.
  • Funds reported $1.34B of Replimune Group stock for Q2 2021, up 26% quarter-over-quarter.
  • 15 funds opened new Replimune Group positions in Q2 2021 and 12 closed out, a net change of +3 holders.
  • The largest Replimune Group buyer in Q2 2021 was T. Rowe Price Associates, an estimated $68.1M added.
  • The largest Replimune Group seller in Q2 2021 was Corriente Advisors, an estimated $21.4M sold.

Based on aggregated 13F filings for Q2 2021.